Article info
PDFCommentary
HPV mRNA testing in cervical cancer screening: implications for low- and middle-income countries
- Correspondence to Edward Christopher Dee, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; deee1{at}mskcc.org
Citation
HPV mRNA testing in cervical cancer screening: implications for low- and middle-income countries
Publication history
- Received August 29, 2022
- Accepted September 7, 2022
- First published October 11, 2022.
Article Versions
- You are currently viewing a Previous version of this article (5 December 2022).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.